Skip to main content
. 2021 Jun 19;3(5):722–731.e1. doi: 10.1016/j.xkme.2021.04.008

Table 3.

Atherosclerotic Cardiovascular Disease Event Rates and Hazard Ratios by the 2018 AHA/ACC Atherosclerotic Cardiovascular Disease Risk Categories and Estimated Glomerular Filtration Rate Levels

Outcomes ASCVD Risk Category
No History of Major ASCVD Events History of 1 Major ASCVD Event With Multiple High-Risk Conditions History of ≥2 Major ASCVD Events
eGFR < 30 mL/min/1.73 m2 n=279 n=135 n=61
ASCVD events
 Events/person-years 59/2,017 53/718 22/284
 Unadjusted rate 29.3 (21.8-36.7) 73.8 (53.9-93.7) 77.5 (53.9-93.7)
 Adjusted rate 38.8 (27.9-49.8) 83.0 (59.5-106.5) 81.8 (41.3-122.3)
 Adjusted rate difference 0.0 (reference) 44.2 (18.2-70.1) 43.0 (1.03-84.9)
 Hazard ratio 1.0 (reference) 1.85 (1.26-2.72) 1.76 (1.07-2.92)
Myocardial infarction
 Events/person-years 43/2,097 35/783 14/318
 Unadjusted rate 20.5 (14.4-26.6) 44.7 (29.9-59.5) 44.0 (20.9-67.0)
 Adjusted rate 26.1 (17.5-34.8) 50.9 (33.4-68.4) 49.1 (17.6-80.6)
 Adjusted rate difference 0.0 (reference) 24.8 (5.2-44.3) 23.0 (−9.7-55.6)
 Hazard ratio 1.0 (reference) 1.56 (0.98-2.49) 1.41 (0.77-2.58)
Ischemic stroke
 Events/person-years 8/2,196 11/867 3/336
 Unadjusted rate 3.6 (1.1-6.2) 12.7 (5.2-20.2) 8.9 (0.0-19.0)a
 Adjusted rate 5.0 (1.2-8.4) 13.2 (5.0-21.5) 16.7 (0.0-42.7)a
 Adjusted rate difference 0.0 (reference) 8.2 (−0.9-17.3) 11.7 (−14.6-37.9)
 Hazard ratio 1.0 (reference) 2.69 (1.03-7.03) 1.64 (0.44-6.16)
Peripheral artery disease
 Events/person-years 20/2,132 19/848 8/317
 Unadjusted rate 9.4 (5.3-13.5) 22.4 (12.3-32.5) 25.2 (7.8-42.8)
 Adjusted rate 12.0 (6.3-17.8) 24.6 (13.1-36.2) 25.7 (6.7-44.8)
 Adjusted rate difference 0.0 (reference) 12.6 (−0.3-25.5) 13.7 (−6.2-33.6)
 Hazard ratio 1.0 (reference) 2.07 (1.06-4.03) 2.07 (0.87-4.95)
eGFR 30 to <45 mL/min/1.73 m2 n=380 n=169 n=57
ASCVD events
 Events/person-years 61/3,221 57/1,205 20/326
 Unadjusted rate 18.9 (14.2-23.7) 47.3 (35.0-59.6) 61.3 (34.5-88.3)
 Adjusted rate 20.2 (14.9-25.4) 50.4 (37.0-63.7) 70.7 (37.6-103.8)
 Adjusted rate difference 0.0 (reference) 30.2 (15.8-44.6) 50.5 (17.0-84.0)
 Hazard ratio 1.0 (reference) 2.18 (1.52-3.14) 2.37 (1.40-4.02)
Myocardial infarction
 Events/person-years 38/3,276 41/1,273 10/374
 Unadjusted rate 11.6 (7.9-15.3) 32.2 (22.3-42.1) 26.7 (10.2-43.3)
 Adjusted rate 12.9 (8.7-17.1) 34.1 (23.5-44.7) 28.0 (9.9-46.1)
 Adjusted rate difference 0.0 (reference) 21.2 (9.8-32.6) 15.1 (−3.5-33.7)
 Hazard ratio 1.0 (reference) 2.37 (1.51-3.73) 1.70 (0.82-3.52)
Ischemic stroke
 Events/person-years 21/3,369 13/1,349 5/401
 Unadjusted rate 6.2 (3.6-8.9) 9.6 (4.4-14.9) 12.5 (1.5-23.4)
 Adjusted rate 6.0 (3.3-8.7) 10.7 (4.7-16.6) 12.2 (1.1-23.3)
 Adjusted rate difference 0.0 (reference) 4.7 (−1.8-11.2) 6.2 (−5.2-17.6)
 Hazard ratio 1.0 (reference) 1.35 (0.67-2.70) 1.49 (0.57-3.88)
Peripheral artery disease
 Events/person-years 11/3,379 19/1,342 7/384
 Unadjusted rate 3.3 (1.3-5.2) 14.2 (7.8-20.5) 18.2 (4.7-31.8)
 Adjusted rate 3.9 (1.6-6.3) 15.1 (8.1-22.0) 18.4 (4.0-32.8)
 Adjusted rate difference 0.0 (reference) 11.2 (3.8-18.5) 14.5 (−0.1-29.1)
 Hazard ratio 1.0 (reference) 3.87 (1.84-8.15) 4.24 (1.60-11.20)
eGFR ≥45 mL/min/1.73 m2 n=409 n=166 n=40
ASCVD events
 Events/person-years 56/3,782 38/1,387 17/289
 Unadjusted rate 14.8 (10.9-18.7) 27.4 (18.7-36.1) 58.8 (30.8-86.6)
 Adjusted rate 15.0 (10.6-19.4) 26.6 (17.8-35.5) 67.5 (30.8-104.1)
 Adjusted rate difference 0.0 (reference) 11.6 (1.8-21.5) 52.5 (15.6-89.4)
 Hazard ratio 1.0 (reference) 1.66 (1.10-2.51) 3.69 (2.10-6.48)
Myocardial infarction
 Events/person-years 36/3,867 25/1,448 7/335
 Unadjusted rate 9.3 (6.3-12.4) 17.3 (10.5-24.0) 20.9 (5.4-36.4)
 Adjusted rate 10.2 (6.5-13.9) 18.1 (10.7-25.5) 20.7 (4.5-37.0)
 Adjusted rate difference 0.0 (reference) 7.9 (−0.3-16.2) 10.5 (−6.1-27.2)
 Hazard ratio 1.0 (reference) 1.66 (0.98-2.79) 1.98 (0.85-4.60)
Ischemic stroke
 Events/person-years 12/4,013 6/1,516 9/332
 Unadjusted rate 3.0 (1.3-4.7) 4.0 (0.8-7.1) 27.1 (9.4-44.8)
 Adjusted rate 2.7 (1.0-4.3) 3.6 (0.6-6.6) 31.1 (8.0-54.2)
 Adjusted rate difference 0.0 (reference) 0.9 (−2.5-4.3) 28.4 (5.3-51.6)
 Hazard ratio 1.0 (reference) 1.19 (0.46-3.13) 8.30 (3.59-19.22)
Peripheral artery disease
 Events/person-years 14/3,971 8/1,501 7/338
 Unadjusted rate 3.5 (1.7-9.0) 5.3 (1.6-9.0) 20.7 (5.4-36.0)
 Adjusted rate 3.5 (1.4-5.5) 4.4 (1.3-7.4) 25.4 (4.9-45.8)
 Adjusted rate difference 0.0 (reference) 0.9 (−2.8-4.6) 21.9 (1.3-42.5)
 Hazard ratio 1.0 (reference) 1.27 (0.54-2.99) 5.34 (2.15-13.28)

Values between parenthesis indicate 95% CI. Rates and rate differences are expressed per 1,000 person-years. Adjusted rates were calculated using direct standardization, with the standard population being all participants with very high ASCVD risk: men <55 years (8.7%), 55 to 65 years (24.4%), 65 to 70 years (15.1%), and ≥70 years (14.2%); women <55 years (5.9%), 55 to 65 years (14.7%), 65 to 70 years (8.7%), ≥70 years (8.3%). Hazard ratios were adjusted for age and sex, and account for the competing risk of death. There were 57 participants with missing eGFR who were not included in this table. ASCVD events include myocardial infarction, ischemic stroke, or peripheral artery disease.

Abbreviations: ACC, American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; CI, confidence interval; eGFR, estimated glomerular filtration rate.

a

A lower 95% CI <0 was calculated. However, we reported a lower 95% CI of zero instead as rates cannot be negative.